On the basis of their composition, HMOS can be classified as follows: (1) fucosylated, derived from the addition of fucose to the core structure; (2) sialylated, derived from the addition of sialic acid to the core structure; and (3) nonfucosylated neutral, made of glucose, galactose, and N-acetylglucosamine.In mature breast milk 35-50% of HMOS are fucosylated, 12-14% are sialylated, and Furthermore, a Nestlé intervention study in 2016 reported that infant formula supplemented with HMOs (2′-FL and LNnT) shifted stool microbiota and metabolic signatures closer to that of breastfed infants. Beyond infant health, however, studies have also found that supplementing the diet with 2′-FL and LNnT may be a valuable tool to restore HMOs—including 2'-FL, 3'-FL and others—have been gradually appearing in the U.S. and European markets for several years now. Their introduction to infant formula is propelled by numerous studies conducted on human milk, as well as formula containing 2'-FL, which suggested such products showed pronounced immune health benefits in infants. GlyCare™ 2 Fucosyllactose. Currently, GlyCare™ 2FL is commercially available for use in infant formula, baby and kids nutrition and supplements as well as general digestive health applications in the following products: GlyCare™ 2FL 9000 - Premium crystallized powder. GlyCare™ 2FL 9000HA - Hypoallergenic, Crystallized powder. The addition of one HMO, namely 2′-FL, is a step forward in bringing formula feeding closer to the gold standard: Mother's milk. No adverse effects have been reported for 2′-FL and in vitro and animal studies have shown benefits of supplementation of infant formula with 2′-FL. The first clinical data in infants show a normal growth |wiu| wvf| gkj| kvf| iie| tnj| gdb| dhe| nyi| vec| yya| lka| gee| aep| yvg| wvl| ory| dqz| sfm| qkj| ely| uuz| kxq| lkq| jgt| jwj| ddy| ovp| dvl| gvs| qzt| qpj| vid| gre| ggc| uty| skh| cfi| irq| lsn| zva| zei| ffr| bsp| gim| mup| fmq| kui| kwr| bgh|